DCM Foundation
Heartfelt Thanks
to our Sponsors

Exciting News from Tenaya Therapeutics

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a biotechnology company with a mission to discover, develop and deliver curative therapies that address the underlying causes of heart disease, today announced that it has completed the build-out and operational launch of its Genetic Medicines Manufacturing Center in Union City, California.

Tenaya is advancing a pipeline of therapeutic candidates, including several adeno-associated virus (AAV) gene therapies, for the potential treatment of both rare and prevalent forms of heart disease.

Click here to read the full article.

Connect with us!
Facebook Instagram Twitter YouTube

Contact Us


7826 Kate Brown Drive
Dublin, Ohio 43017